A Woman's Journey: New Treatment for Depression
Medicine & Public Health
•
59m
There's good news for people who suffer with severe treatment-resistant depression. Esketamine is a groundbreaking therapy that may provide relief from major depression within hours. Join this livestream to hear psychiatrist Erica Richards, chair and medical director of the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital, describe who is a candidate for esketamine, which is derived from an anesthetic called ketamine, and how it works, and psychopharmacologist Roland Griffiths, Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, will tell us about psilocybin research and risk factors of the drug. To learn more, visit jhu.edu/hopkinsathome
Up Next in Medicine & Public Health
-
A Woman's Journey: New Findings from ...
Preventive cardiologist and women’s heart health expert, Dr. Erin Michos, reviews new findings released at the most recent annual American Heart Association Scientific Sessions.
Erin D. Michos, MD, MHS '07 is an Associate Professor of Medicine within the Division of Cardiology at Johns Hopkins S...
-
A Woman's Journey Managing Your Micro...
A Woman's Journey: Conversations that Matter December's monthly Hopkins at Home features infectious disease and cancer researcher Dr. Cynthia Sears discussing what the microbiome is, what changes it, and how emerging discoveries have revealed its broad impact on health and disease. Dr. Sears disc...
-
A Woman's Journey: Improving Survival...
Early detection plays a vital role in treating pancreatic cancer and increases the chance of surviving the lethal disease. Learn from cancer pathologist Michael Goggins, director of the Pancreatic Cancer Early Detection Laboratory, about new strategies — including identifying gene variants respon...
